Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs-Reference-Cited by-同舟云学术

Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs

Published:2015-08-24 Issue:9 Volume:12 Page:3369-3379
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Tronino Diana¹,Russo Roberto¹,Ostacolo Carmine¹,Mazzolari Angelica²,De Caro Carmen¹,Avagliano Carmen¹,Laneri Sonia¹,La Rana Giovanna¹,Sacchi Antonia¹,Della Valle Francesco³,Vistoli Giulio²,Calignano Antonio¹

Affiliation:

1. Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy

2. Department of Pharmaceutical Sciences “Pietro Pratesi”, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy

3. Epitech Group s.r.l., Via Egadi 7, 20144 Milan, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00397

Reference49 articles.

1. Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α

2. The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

3. Control of pain initiation by endogenous cannabinoids

4. Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-α receptor agonist GW7647

5. Differential Expression of Peroxisome Proliferator-Activated Receptor-α, -β, and -γ during Rat Embryonic Development*

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Group IVE cytosolic phospholipase A ₂ limits psoriatic inflammation by mobilizing the anti‐inflammatory lipid N ‐acylethanolamine;The FASEB Journal;2022-04-28

2. Oxidative Stress and Its Consequences in the Blood of Rats Irradiated with UV: Protective Effect of Cannabidiol;Antioxidants;2021-05-21

3. Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease;Frontiers in Pharmacology;2019-07-24

4. Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?;Drug Design, Development and Therapy;2016-09

5. Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo;Colloids and Surfaces B: Biointerfaces;2016-05